ATE407708T1 - Vorrichtung und verfahren zur behandlung von dermatomykosen und insbesondere onychomykosen - Google Patents

Vorrichtung und verfahren zur behandlung von dermatomykosen und insbesondere onychomykosen

Info

Publication number
ATE407708T1
ATE407708T1 AT06708228T AT06708228T ATE407708T1 AT E407708 T1 ATE407708 T1 AT E407708T1 AT 06708228 T AT06708228 T AT 06708228T AT 06708228 T AT06708228 T AT 06708228T AT E407708 T1 ATE407708 T1 AT E407708T1
Authority
AT
Austria
Prior art keywords
nitric oxide
eluting polymer
onychomycoses
dermatomycoses
treating
Prior art date
Application number
AT06708228T
Other languages
English (en)
Inventor
Tor Peters
Original Assignee
Nolabs Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05002936A external-priority patent/EP1690554A1/de
Priority claimed from EP05018269A external-priority patent/EP1757278A1/de
Application filed by Nolabs Ab filed Critical Nolabs Ab
Application granted granted Critical
Publication of ATE407708T1 publication Critical patent/ATE407708T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/10—Bandages or dressings; Absorbent pads specially adapted for fingers, hands or arms; Finger-stalls; Nail-protectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/10—Bandages or dressings; Absorbent pads specially adapted for fingers, hands or arms; Finger-stalls; Nail-protectors
    • A61F13/104—Bandages or dressings; Absorbent pads specially adapted for fingers, hands or arms; Finger-stalls; Nail-protectors for the hands or fingers
    • A61F13/105—Bandages or dressings; Absorbent pads specially adapted for fingers, hands or arms; Finger-stalls; Nail-protectors for the hands or fingers for the fingers; Finger-stalls; Nail-protectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B21/00—Nitrogen; Compounds thereof
    • C01B21/20—Nitrogen oxides; Oxyacids of nitrogen; Salts thereof
    • C01B21/24—Nitric oxide (NO)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/06—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings
    • A61F13/064—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings for feet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/06—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings
    • A61F13/064—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings for feet
    • A61F13/068—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings for feet for the toes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AT06708228T 2005-02-11 2006-02-13 Vorrichtung und verfahren zur behandlung von dermatomykosen und insbesondere onychomykosen ATE407708T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05002936A EP1690554A1 (de) 2005-02-11 2005-02-11 Vorrichtung zur Behandlung von Infektionen und insbesondere von Onychomykose und Dermatophytose
US65275905P 2005-02-14 2005-02-14
EP05018269A EP1757278A1 (de) 2005-08-23 2005-08-23 Vorrichtung, System und Methode enthaltend eine verkapselte Flüssigkeit zur Stickstoffmonoxyd-Freisetzung von einem Polymer
US71100605P 2005-08-24 2005-08-24

Publications (1)

Publication Number Publication Date
ATE407708T1 true ATE407708T1 (de) 2008-09-15

Family

ID=39189566

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06708228T ATE407708T1 (de) 2005-02-11 2006-02-13 Vorrichtung und verfahren zur behandlung von dermatomykosen und insbesondere onychomykosen

Country Status (14)

Country Link
US (1) US20080071206A1 (de)
EP (1) EP1861130B1 (de)
JP (1) JP2008529626A (de)
KR (1) KR20070104408A (de)
AT (1) ATE407708T1 (de)
BR (1) BRPI0606829A2 (de)
CA (1) CA2594408A1 (de)
DE (1) DE602006002726D1 (de)
DK (1) DK1861130T3 (de)
ES (1) ES2314882T3 (de)
MX (1) MX2007009691A (de)
PL (1) PL1861130T3 (de)
PT (1) PT1861130E (de)
WO (1) WO2006084910A2 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1718603A4 (de) 2004-02-09 2009-09-23 Noxilizer Inc Stickstoffmonoxid freisetzende moleküle
WO2006100154A1 (en) 2005-03-24 2006-09-28 Nolabs Ab Cosmetic treatment with nitric oxide, device for performing said treatment and manufacturing method therefor
CA2606565C (en) 2005-05-27 2016-05-10 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
SE529056C2 (sv) 2005-07-08 2007-04-17 Plasma Surgical Invest Ltd Plasmaalstrande anordning, plasmakirurgisk anordning och användning av en plasmakirurgisk anordning
SE529058C2 (sv) 2005-07-08 2007-04-17 Plasma Surgical Invest Ltd Plasmaalstrande anordning, plasmakirurgisk anordning, användning av en plasmakirurgisk anordning och förfarande för att bilda ett plasma
SE529053C2 (sv) 2005-07-08 2007-04-17 Plasma Surgical Invest Ltd Plasmaalstrande anordning, plasmakirurgisk anordning och användning av en plasmakirurgisk anordning
US7928338B2 (en) * 2007-02-02 2011-04-19 Plasma Surgical Investments Ltd. Plasma spraying device and method
BRPI0721507A2 (pt) * 2007-03-27 2013-01-08 Nolabs Ab dispositivo de dispensaÇço de àxido nÍtrico tàpico, kit, uso de àxido nÍtrico, e, mÉtodos de dispensaÇço tàpica de àxido nÍtrico e de tratamento
US7589473B2 (en) * 2007-08-06 2009-09-15 Plasma Surgical Investments, Ltd. Pulsed plasma device and method for generating pulsed plasma
US8735766B2 (en) * 2007-08-06 2014-05-27 Plasma Surgical Investments Limited Cathode assembly and method for pulsed plasma generation
CN101835502A (zh) 2007-09-21 2010-09-15 伊诺克斯生物制药公司 释放抗微生物气体的耳引流管
CA2728789A1 (en) * 2008-06-24 2009-12-30 Micropharma Limited Nitric oxide compositions and devices and methods for cosmesis
GB0901456D0 (en) * 2009-01-29 2009-03-11 Insense Ltd Treatment of psoriasis
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
WO2011022680A2 (en) 2009-08-21 2011-02-24 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
US8613742B2 (en) * 2010-01-29 2013-12-24 Plasma Surgical Investments Limited Methods of sealing vessels using plasma
WO2011127181A2 (en) * 2010-04-06 2011-10-13 Syracuse University System and method for the release of nitric oxide using nanoscale media
CN102917712B (zh) * 2010-05-03 2015-09-02 斯彭科医疗公司 指/趾甲变色及真菌疗法
WO2011155887A1 (en) * 2010-06-07 2011-12-15 Topical Pharma Ab Kit for the treatment of onychomycosis by nitric oxide
US9089319B2 (en) 2010-07-22 2015-07-28 Plasma Surgical Investments Limited Volumetrically oscillating plasma flows
US20120023634A1 (en) * 2010-08-02 2012-02-02 Jeffrey Lynn Kiser Male pant protector
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118819A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
BR112014000178A2 (pt) 2011-07-05 2017-02-07 Novan Inc composições tópicas
WO2013006613A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Methods of manufacturing topical compositions and apparatus for same
CN104302175B (zh) 2012-03-14 2017-04-12 诺万公司 释放一氧化氮的药物组合物
US9480829B2 (en) 2013-01-17 2016-11-01 Tamicare Ltd. All direction stretchable dressing article associated with curable materials
US9675817B2 (en) 2013-01-23 2017-06-13 Jonathan Isserow Heating device using exothermic chemical reaction
US10583037B2 (en) 2013-01-23 2020-03-10 Transqtronics, Llc. Heating device using exothermic chemical reaction
US10010445B2 (en) 2013-01-23 2018-07-03 Jonathan Isserow Treatment device using nanotechnology
US9636521B2 (en) 2013-07-12 2017-05-02 Jonathan Isserow Heat and light treatment device using nanotechnology
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
KR102428738B1 (ko) 2013-08-08 2022-08-02 노반, 인크. 국소 조성물 및 그의 사용 방법
EP3698775A1 (de) 2014-07-11 2020-08-26 Novan Inc. Topische antivirale zusammensetzungen und verfahren zu deren verwendung
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
US10925689B2 (en) 2014-07-14 2021-02-23 Novan, Inc. Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
CA2919733A1 (en) 2014-08-08 2016-02-08 Novan, Inc. Topical compositions and methods of using the same
US10849864B2 (en) 2015-07-28 2020-12-01 Novan, Inc. Combinations and methods for the treatment and/or prevention of fungal infections
KR102319497B1 (ko) 2016-03-02 2021-11-01 노반, 인크. 염증 치료용 조성물 및 염증 치료 방법
CN116585257A (zh) * 2016-04-13 2023-08-15 诺万公司 用于治疗感染的组合物、系统、试剂盒和方法
US10568769B2 (en) * 2016-05-27 2020-02-25 Evadne I. Hutchful Fabric sleeves covering toe and finger blemishes and treating said blemishes
JP2021515807A (ja) 2018-03-01 2021-06-24 ノーバン，インク． 一酸化窒素放出性坐剤及びその使用の方法
CN110052995B (zh) * 2019-05-30 2024-03-29 山东交通学院 一种辅助拇指指甲及活塞环拆装工具
WO2020250036A1 (en) * 2019-06-12 2020-12-17 Sanotize Research And Development Corp. Medicament containment devices and associated compositions
US20230256217A1 (en) * 2020-07-23 2023-08-17 Purdue Research Foundation Ozone generation apparatuses and methods of treating wounds
EP4205515A2 (de) 2020-08-28 2023-07-05 Plasma Surgical Investments Limited Systeme, verfahren und vorrichtungen zur erzeugung eines überwiegend radial expandierten plasmaflusses
FR3140537A1 (fr) * 2022-10-07 2024-04-12 HealthRock Capital SA Dispositif médical apte à couvrir l’ongle d’un orteil ou d’un doigt

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814666A (en) * 1992-04-13 1998-09-29 The United States As Represented By The Department Of Health And Human Services Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
US5691423A (en) * 1992-08-24 1997-11-25 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-bound nitric oxide-nucleophile adducts
US5405919A (en) * 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
KR100385297B1 (ko) * 1994-02-21 2003-10-10 에이버딘 유니버시티 항균제로서의산성화아질산염
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
US5519020A (en) * 1994-10-28 1996-05-21 The University Of Akron Polymeric wound healing accelerators
EP0805662B1 (de) * 1995-01-26 2000-11-02 Advanced Medical Solutions Limited Wundverband
US5770645A (en) * 1996-08-02 1998-06-23 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US5958427A (en) * 1996-11-08 1999-09-28 Salzman; Andrew L. Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
US20040043068A1 (en) * 1998-09-29 2004-03-04 Eugene Tedeschi Uses for medical devices having a lubricious, nitric oxide-releasing coating
WO2000022207A2 (en) * 1998-10-01 2000-04-20 The University Of Akron Process and apparatus for the production of nanofibers
US6737447B1 (en) * 1999-10-08 2004-05-18 The University Of Akron Nitric oxide-modified linear poly(ethylenimine) fibers and uses thereof
US6627301B2 (en) * 2000-03-28 2003-09-30 Showa Denko Kabushiki Kaisha Magnetic recording medium
HUP0002628A2 (en) * 2000-07-14 2002-06-29 Keri Pharma Kft Pharmaceutical combinations for treating diabetes
US6780849B2 (en) * 2000-12-21 2004-08-24 Scimed Life Systems, Inc. Lipid-based nitric oxide donors
US6706274B2 (en) * 2001-01-18 2004-03-16 Scimed Life Systems, Inc. Differential delivery of nitric oxide
US6520425B1 (en) * 2001-08-21 2003-02-18 The University Of Akron Process and apparatus for the production of nanofibers
US6703046B2 (en) * 2001-10-04 2004-03-09 Medtronic Ave Inc. Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use
US6695992B2 (en) * 2002-01-22 2004-02-24 The University Of Akron Process and apparatus for the production of nanofibers
CA2478320A1 (en) * 2002-03-07 2003-09-18 Board Of Regents, The University Of Texas System Conformable bi-laminate compression bolster and method for using same
EP1545798A4 (de) * 2002-08-02 2006-06-14 Us Gov Health & Human Serv Vernetzte stickstoffoxid freisetzende polyaminbeschichtete substrate, diese enthaltenden zusammensetzungen und herstellungsverfahren daf r
US7972137B2 (en) * 2003-06-30 2011-07-05 Rosen Gerald M Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease
WO2005003032A1 (en) * 2003-07-03 2005-01-13 The University Court Of The University Of St Andrews Zeolites for delivery of nitric oxide
WO2006058318A2 (en) * 2004-11-29 2006-06-01 The University Of Akron Topical nitric oxide donor devices

Also Published As

Publication number Publication date
WO2006084910A3 (en) 2007-03-08
EP1861130A2 (de) 2007-12-05
DK1861130T3 (da) 2009-01-26
DE602006002726D1 (de) 2008-10-23
JP2008529626A (ja) 2008-08-07
BRPI0606829A2 (pt) 2009-07-21
CA2594408A1 (en) 2006-08-17
EP1861130B1 (de) 2008-09-10
PL1861130T3 (pl) 2009-02-27
KR20070104408A (ko) 2007-10-25
MX2007009691A (es) 2008-02-12
PT1861130E (pt) 2008-12-02
ES2314882T3 (es) 2009-03-16
WO2006084910A2 (en) 2006-08-17
US20080071206A1 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
ATE407708T1 (de) Vorrichtung und verfahren zur behandlung von dermatomykosen und insbesondere onychomykosen
DE602006006432D1 (de) Kosmetische behandlung mit stickoxid, vorrichtung zur durchführung dieser behandlung und herstellungsverfahren dafür
CR20240003A (es) Restos de administración terapéutica novedosos y usos de estos
BRPI0606834A2 (pt) usos de óxido nìtrico (no), dispositivo não implantável configurado, processo para fabricação de dispositivo configurado, uso de polìmero eluente de óxido nìtrico (no) e método de tratamento
MY141025A (en) Dose forms
EP2493464A4 (de) Methylsulfonylmethan (msm) zur behandlung wirkstoffresistenter mikroorganismen
MX353964B (es) Agentes terapeuticos y usos de los mismos.
EP4434540A3 (de) Humanisierte anti-il-1r3-antikörper
NO20071428L (no) Kombinasjon inneholdende ZD6474 og Imatinib
DE60136826D1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
EP4279128A3 (de) Neuartige antikörper mit bindung an tfpi und zusammensetzung damit
ZA202302155B (en) Interferon-based cancer treatment method and pharmaceutical composition
BR112023018237A2 (pt) Fenalquilaminas e métodos para fabricação e uso das mesmas
EP4310093A4 (de) Aminosäurederivat, herstellungsverfahren dafür und pharmazeutische zusammensetzung zur behandlung von hepatitis damit
WO2006100156A3 (en) Intravascular, interstitial or intraorgan medical access device, and manufacturing method thereof, involving nitric oxide
EP1969003A4 (de) Neues neurotropischer-faktor-protein und anwendungen davon
MY185942A (en) Selected amide of y-hydroxybutyric acid and uses thereof in the treatment of alcohol misuse
ECSP066805A (es) Compuestos silinano como inhibidores de cisteína proteasa
WO2007149382A3 (en) Therapeutic compositions and methods useful in treating hepatitis
ATE406171T1 (de) Aplidine zur behandlung von multiplem myelom
BR112022004941A2 (pt) Métodos para tratar doenças autoimunes com o uso de antagonistas de interleucina-17 (il-17)
DE602006020919D1 (de) Kombination aus azd2171 und pemetrexed
ATE409039T1 (de) Kombinationstherapie gegen krebserkrankungen mit azd2171 und zd1839
WO2008109521A3 (en) Method of treatment using atranorin
NO20064753L (no) Kombinasjonsterapi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1861130

Country of ref document: EP

REN Ceased due to non-payment of the annual fee